Report: Cancer Genetic Test Gets More Affordable
The price tag of genetic tests for breast and ovarian cancer can reach thousands of dollars. What if genetic testing was cheaper? California-based Color Genomics has launched a $249 genetic test that can be done at home and analyzes a saliva sample for mutations in the breast cancer gene BRCA1 and BRCA2, which identify a woman's risk for cancer, according to U.S. News & World Report. "Color's goal is to democratize access to genetic testing, starting with breast and ovarian cancer risk testing," Elad Gil, one of the company's co-founders, told NPR Health. This could mean greater accessibility for genetic testing among Latinas. Latinas are 20% more likely to die from breast cancer than white non-Hispanic women at the same age and stage. Yet genetic testing isn't as common among ...
Read More